Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | PRKDC | P78527 | 2/20 | 0.37 |
| ▸ | TDO2 | P48775 | 7/20 | 0.34 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 4/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 2/20 | 0.32 |
| ▸ | HTR5A | P47898 | 2/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754697 | 0.98 | ALOX5 (0.46) | ALOX5PRKDCTDO2DNPH1LIMK1 | |
| SCHEMBL17754693 | 0.94 | ALOX5 (0.43) | ALOX5PRKDCTDO2DNPH1LIMK1 | |
| SCHEMBL17754685 | 0.94 | ALOX5 (0.43) | ALOX5PRKDCTDO2DNPH1LIMK1 | |
| SCHEMBL26238249 | 0.91 | TNKS (0.37) | ALOX5TDO2LIMK1IDO1TNKS | |
| SCHEMBL17754643 | 0.90 | ALOX5 (0.57) | ALOX5PRKDCTDO2DNPH1LIMK1 | |
| SCHEMBL17754690 | 0.89 | ALOX5 (0.43) | ALOX5PRKDCTDO2DNPH1LIMK1 | |
| SCHEMBL14948276 | 0.88 | TNKS (0.34) | ALOX5TDO2LIMK1IDO1TNKS | |
| SCHEMBL17754687 | 0.88 | ALOX5 (0.38) | ALOX5PRKDCTDO2DNPH1 | |
| SCHEMBL17754638 | 0.87 | ALOX5 (0.56) | ALOX5PRKDCTDO2DNPH1LIMK1 | |
| SCHEMBL13681149 | 0.86 | ALOX5 (0.52) | ALOX5PRKDCLIMK1PARP14TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9761814-B2 | Organic light-emitting materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-12 | — | — | US | disclosed |
| US-9761814-B2 | Organic light-emitting materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-12 | — | — | US | disclosed |
| US-20160141525-A1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160141525-A1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBPL3 | ALOX5 234/4885PRKDC 3373/4885TDO2 893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.